## Abstract Valve replacement is the most common surgical treatment in patients with advanced valvular heart disease. Mechanical and bioβprostheses have been the traditional heart valve replacements in these patients. However, currently the heart valves for replacement therapy are imperfect and sub
Limitations of enzyme replacement therapy: Current and future
β Scribed by J. E. Wraith
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 228 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## ABSTRACT Fabry disease is a multisystem disorder associated with wide variability in clinical expression. Fabry disease is an Xβlinked lysosomal storage disorder caused by a deficiency of Ξ±βgalactosidaseΒ A. The enzyme defect leads to the systemic accumulation of glycosphingolipids with Ξ±βgalacto
Photodynamic therapy (PDT) may offer an enhanced therapeutic index via one or more of the following modalities: a) preferential photosensitizer uptake by the target tissue, b) specific illumination of target tissue to excite the photosensitizer, c) strategic timing of light application to minimize t